Prevention of influenza disease caused by 2 influenza A virus subtypes & 2 influenza B virus subtypes, for active immunisation of adults, pregnant women, & childn from 6 mth; & passive protection of infants <6 mth & born to women vaccinated during pregnancy.
IM/SC Adult, pregnant woman, childn 6 mth to 17 yr 0.5 mL as a single dose. Childn <9 yr & those who have not been previously vaccinated Administer 2nd dose of 0.5 mL after at least 4 wk.
Hypersensitivity to influenza vaccine, eggs (ovalbumin, chicken proteins), neomycin, formaldehyde or octoxinol-9. Illness w/ high or moderate temp or acute illness.
Not to be administered intravascularly. Patients w/ immunodeficiency or taking medicines affecting the immune system; w/ bleeding problem & bruise easily. Fainting. False +ve blood test results may occur. Not recommended for childn <6 mth.